578 related articles for article (PubMed ID: 7479695)
1. Structural basis for serpin inhibitor activity.
Wright HT; Scarsdale JN
Proteins; 1995 Jul; 22(3):210-25. PubMed ID: 7479695
[TBL] [Abstract][Full Text] [Related]
2. Modeling of serpin-protease complexes: antithrombin-thrombin, alpha 1-antitrypsin (358Met-->Arg)-thrombin, alpha 1-antitrypsin (358Met-->Arg)-trypsin, and antitrypsin-elastase.
Whisstock J; Lesk AM; Carrell R
Proteins; 1996 Nov; 26(3):288-303. PubMed ID: 8953650
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator inhibitor 1. Structure of the native serpin, comparison to its other conformers and implications for serpin inactivation.
Nar H; Bauer M; Stassen JM; Lang D; Gils A; Declerck PJ
J Mol Biol; 2000 Mar; 297(3):683-95. PubMed ID: 10731421
[TBL] [Abstract][Full Text] [Related]
4. Rational design of complex formation between plasminogen activator inhibitor-1 and its target proteinases.
Aertgeerts K; De Ranter CJ; Booth NA; Declerck PJ
J Struct Biol; 1997 Apr; 118(3):236-42. PubMed ID: 9169233
[TBL] [Abstract][Full Text] [Related]
5. The structural puzzle of how serpin serine proteinase inhibitors work.
Wright HT
Bioessays; 1996 Jun; 18(6):453-64. PubMed ID: 8787534
[TBL] [Abstract][Full Text] [Related]
6. Evolutionary relationships among the serpins.
Marshall CJ
Philos Trans R Soc Lond B Biol Sci; 1993 Oct; 342(1300):101-19. PubMed ID: 7904353
[TBL] [Abstract][Full Text] [Related]
7. The cowpox virus serpin SPI-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin.
Turner PC; Baquero MT; Yuan S; Thoennes SR; Moyer RW
Virology; 2000 Jul; 272(2):267-80. PubMed ID: 10873770
[TBL] [Abstract][Full Text] [Related]
8. Serpins: finely balanced conformational traps.
Pike RN; Bottomley SP; Irving JA; Bird PI; Whisstock JC
IUBMB Life; 2002 Jul; 54(1):1-7. PubMed ID: 12387568
[TBL] [Abstract][Full Text] [Related]
9. The role of strand 1 of the C beta-sheet in the structure and function of alpha(1)-antitrypsin.
Bottomley SP; Lawrenson ID; Tew D; Dai W; Whisstock JC; Pike RN
Protein Sci; 2001 Dec; 10(12):2518-24. PubMed ID: 11714919
[TBL] [Abstract][Full Text] [Related]
10. Probing the local conformational change of alpha1-antitrypsin.
Baek JH; Im H; Kang UB; Seong KM; Lee C; Kim J; Yu MH
Protein Sci; 2007 Sep; 16(9):1842-50. PubMed ID: 17660256
[TBL] [Abstract][Full Text] [Related]
11. The role of conformational change in serpin structure and function.
Gettins P; Patston PA; Schapira M
Bioessays; 1993 Jul; 15(7):461-7. PubMed ID: 8379949
[TBL] [Abstract][Full Text] [Related]
12. Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1.
Wardell MR; Chang WS; Bruce D; Skinner R; Lesk AM; Carrell RW
Biochemistry; 1997 Oct; 36(42):13133-42. PubMed ID: 9335576
[TBL] [Abstract][Full Text] [Related]
13. Conformational changes in serpins: I. The native and cleaved conformations of alpha(1)-antitrypsin.
Whisstock JC; Skinner R; Carrell RW; Lesk AM
J Mol Biol; 2000 Feb; 296(2):685-99. PubMed ID: 10669617
[TBL] [Abstract][Full Text] [Related]
14. Viscous drag as the source of active site perturbation during protease translocation: insights into how inhibitory processes are controlled by serpin metastability.
Shin JS; Yu MH
J Mol Biol; 2006 Jun; 359(2):378-89. PubMed ID: 16626735
[TBL] [Abstract][Full Text] [Related]
15. Cloning and characterization of hurpin (protease inhibitor 13): A new skin-specific, UV-repressible serine proteinase inhibitor of the ovalbumin serpin family.
Abts HF; Welss T; Mirmohammadsadegh A; Köhrer K; Michel G; Ruzicka T
J Mol Biol; 1999 Oct; 293(1):29-39. PubMed ID: 10512713
[TBL] [Abstract][Full Text] [Related]
16. Role of Lys335 in the metastability and function of inhibitory serpins.
Im H; Yu MH
Protein Sci; 2000 May; 9(5):934-41. PubMed ID: 10850803
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-2 is highly tolerant to P8 residue substitution--implications for serpin mechanistic model and prediction of nsSNP activities.
Di Giusto DA; Sutherland AP; Jankova L; Harrop SJ; Curmi PM; King GC
J Mol Biol; 2005 Nov; 353(5):1069-80. PubMed ID: 16214170
[TBL] [Abstract][Full Text] [Related]
18. A serpin-induced extensive proteolytic susceptibility of urokinase-type plasminogen activator implicates distortion of the proteinase substrate-binding pocket and oxyanion hole in the serpin inhibitory mechanism.
Egelund R; Petersen TE; Andreasen PA
Eur J Biochem; 2001 Feb; 268(3):673-85. PubMed ID: 11168406
[TBL] [Abstract][Full Text] [Related]
19. A model of the reactive form of plasminogen activator inhibitor-1.
Aertgeerts K; De Bondt HL; De Ranter C; Declerck PJ
J Struct Biol; 1994; 113(3):239-45. PubMed ID: 7734247
[TBL] [Abstract][Full Text] [Related]
20. Human neuroserpin: structure and time-dependent inhibition.
Ricagno S; Caccia S; Sorrentino G; Antonini G; Bolognesi M
J Mol Biol; 2009 Apr; 388(1):109-21. PubMed ID: 19265707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
